Skip to Content
Merck
CN

Whole genome microarray analysis in non-small cell lung cancer.

Biotechnology, biotechnological equipment (2015-05-29)
Mohammad Al Zeyadi, Ivanka Dimova, Vladislav Ranchich, Blaga Rukova, Desislava Nesheva, Zora Hamude, Sevdalin Georgiev, Danail Petrov, Draga Toncheva
ABSTRACT

Lung cancer is a serious health problem, since it is one of the leading causes for death worldwide. Molecular-cytogenetic studies could provide reliable data about genetic alterations which could be related to disease pathogenesis and be used for better prognosis and treatment strategies. We performed whole genome oligonucleotide microarray-based comparative genomic hybridization in 10 samples of non-small cell lung cancer. Trisomies were discovered for chromosomes 1, 13, 18 and 20. Chromosome arms 5p, 7p, 11q, 20q and Хq were affected by genetic gains, and 1p, 5q, 10q and 15q, by genetic losses. Microstructural (<5 Mbp) genomic aberrations were revealed: gains in regions 7p (containing the epidermal growth factor receptor gene) and 12p (containing